Precision BioSciences Grants Surge of RSUs to Senior Leaders Amid Volatile Stock—Insider Buy‑Backs Signal Confidence in Future Pipeline
Precision BioSciences sees a strategic shift as senior leaders receive large RSU grants—insider confidence, potential stock stabilization, and a focus on future clinical milestones.
3 minutes to read



